These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1855211)

  • 1. Ionic and ligand-specific effects on the DNA binding of progesterone receptor bound to the synthetic progestin R5020 and the antiprogestin RU486.
    Chao CC; Thomas TJ; Ebede P; Gallo MA; Thomas T
    Cancer Res; 1991 Aug; 51(15):3938-45. PubMed ID: 1855211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High affinity binding of estrogen receptor to recombinant plasmids containing (dA-dC)n.(dG-dT)n sequences.
    Thomas T; Thomas TJ
    Cancer Res; 1989 Sep; 49(17):4734-9. PubMed ID: 2547515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
    Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
    Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of R5020 and RU486 binding to progesterone receptor from calf uterus.
    Hurd C; Moudgil VK
    Biochemistry; 1988 May; 27(10):3618-23. PubMed ID: 3408715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor.
    DeMarzo AM; Oñate SA; Nordeen SK; Edwards DP
    Biochemistry; 1992 Nov; 31(43):10491-501. PubMed ID: 1420166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of human progesterone receptor in the presence of the progestin (R5020) and the antiprogestin (RU486).
    Miller MM; Hurd C; Moudgil VK
    J Steroid Biochem; 1988 Nov; 31(5):777-83. PubMed ID: 3199817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antiestrogen versus antiprogestin on transformed and nontransformed steroid receptors.
    Turner JW; Ruh MF; Ward DT; Ruh TS
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):197-203. PubMed ID: 2004041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian progesterone receptor shows differential sensitivity to sulfhydryl group modifying agents when bound to agonist and antagonist ligands.
    Moudgil VK; Anter MJ; Hurd C
    J Biol Chem; 1989 Feb; 264(4):2203-11. PubMed ID: 2914901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
    Leonhardt SA; Altmann M; Edwards DP
    Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiprogestin-receptor complexes: differences in the interaction of the antiprogestin RU38,486 and the progestin R5020 with the progesterone receptor of human breast cancer cells.
    Mullick A; Katzenellenbogen BS
    Biochem Biophys Res Commun; 1986 Feb; 135(1):90-7. PubMed ID: 3954780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antiprogestins Org 31806 and 31710: interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexes.
    Mizutani T; Bhakta A; Kloosterboer HJ; Moudgil VK
    J Steroid Biochem Mol Biol; 1992 Aug; 42(7):695-704. PubMed ID: 1504008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoanalysis of calf uterine progesterone receptor: modulation of receptor-associated 90 kDa heat-shock protein. f.
    Hurd C; Nakao M; Eliezer N; Moudgil VK
    Mol Cell Biochem; 1991 Jun; 105(1):73-83. PubMed ID: 1922009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone.
    Attardi BJ; Burgenson J; Hild SA; Reel JR
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):277-88. PubMed ID: 15120421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of calf uterine progesterone receptor: analysis of the process when receptor is bound to progesterone and RU38486.
    Moudgil VK; Hurd C
    Biochemistry; 1987 Aug; 26(16):4993-5001. PubMed ID: 3663641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins.
    Terakawa N; Shimizu I; Tanizawa O; Matsumoto K
    J Steroid Biochem; 1988 Aug; 31(2):161-6. PubMed ID: 2457133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
    Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
    Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the binding mechanism of RU486 and progesterone to the progesterone receptor.
    Skafar DF
    Biochemistry; 1991 Nov; 30(45):10829-32. PubMed ID: 1932004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The constitution of a progesterone response element.
    Lieberman BA; Bona BJ; Edwards DP; Nordeen SK
    Mol Endocrinol; 1993 Apr; 7(4):515-27. PubMed ID: 8388996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism.
    Shatnawi A; Tran T; Ratnam M
    Mol Endocrinol; 2007 Mar; 21(3):635-50. PubMed ID: 17192405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiprogesterone RU486 stabilizes the heterooligomeric, non-DNA-binding, 8S-form of the rabbit uterus cytosol progesterone receptor.
    Renoir JM; Radanyi C; Baulieu EE
    Steroids; 1989; 53(1-2):1-20. PubMed ID: 2772964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.